Larry Abensur

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.

Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France.

Prodiag SAS specializes in technical diagnosis for real estate in France, particularly in the Île-de-France region. The company is based in Echbolsheim, France. The French company's services include checking the compliance of asbestos removal operations. Prodiag was acquired by Biosynex SA on April 23, 2015 for $16.17 million.

Dectra Pharm SAS distributes and markets medical diagnostic equipment. It also offers dental health products such as toothbrush, floss, and toothpaste. The company was founded in 1994 and is headquartered in Eckbolsheim, France.